Medicare Enrolled

Dr. Matthew Sheldon, MD

Urology Physician · Orchard Park, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
500 STERLING DR, Orchard Park, NY 14127
7166772273
In practice since 2009 (17 years)
NPI: 1790919728 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sheldon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sheldon? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sheldon

Dr. Matthew Sheldon is an urology physician in Orchard Park, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Sheldon performed 1,927 Medicare services across 1,619 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sheldon received a total of $6,048 from 52 pharmaceutical and/or device companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sheldon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 36% volume in NY $6,048 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,927
Medicare services
Top 36% in NY for urology physician
1,619
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~113 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
769 $2 $15
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
332 $86 $160
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
271 $57 $115
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
237 $7 $85
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
88 $8 $8
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
66 $107 $253
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
31 $61 $120
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
27 $153 $400
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
26 $38 $60
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
15 $77 $177
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
14 $313 $1,000
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
14 $101 $200
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
14 $65 $100
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
12 $115 $870
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
11 $11 $50
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
12.9% medium
85.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,048
Total received (2018-2024)
Avg $864/year across 7 years
Top 26% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
322
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,039 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$719
2023
$1,004
2022
$925
2021
$813
2020
$495
2019
$1,068
2018
$1,023

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$217
PFIZER INC.
$170
Sumitomo Pharma America, Inc.
$81
PROCEPT BioRobotics Corporation
$59
Teleflex LLC
$33
Merck Sharp & Dohme LLC
$29
180 Medical, Inc.
$28
Olympus America Inc.
$22
Ferring Pharmaceuticals Inc.
$22
Dendreon Pharmaceuticals LLC
$19
Novo Nordisk Inc
$19
Myriad Genetic Laboratories, Inc.
$18
Top 3 companies account for 65.2% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,137
PFIZER INC.
$517
ABBVIE INC.
$432
AbbVie Inc.
$418
Janssen Biotech, Inc.
$400
Caldera Medical, Inc
$241
Ferring Pharmaceuticals Inc.
$203
Sumitomo Pharma America, Inc.
$198
Endo Pharmaceuticals Inc.
$190
Dendreon Pharmaceuticals LLC
$188
AbbVie, Inc.
$136
NeoTract Inc.
$123
AstraZeneca Pharmaceuticals LP
$118
Allergan Inc.
$110
Avadel Specialty Pharmaceuticals, LLC
$108
Bayer HealthCare Pharmaceuticals Inc.
$101
Allergan, Inc.
$98
Amgen Inc.
$97
TOLMAR Pharmaceuticals, Inc.
$92
Merck Sharp & Dohme LLC
$90
Teleflex LLC
$86
UROVANT SCIENCES INC
$79
MEDIVATION FIELD SOLUTIONS LLC
$72
Merck Sharp & Dohme Corporation
$72
PROCEPT BioRobotics Corporation
$59
Boston Scientific Corporation
$54
DENTSPLY IH Inc.
$54
DENTSPLY IH AB
$49
180 Medical, Inc.
$48
Myriad Genetic Laboratories, Inc.
$44
Olympus America Inc.
$43
Agiliti Surgical, Inc.
$35
ROCHESTER MEDICAL CORPORATION
$28
Myovant Sciences Inc.
$27
Progenics Pharmaceuticals, Inc.
$26
Egalet US Inc
$25
Accord Healthcare, Inc.
$24
Novo Nordisk Inc
$19
Travere Therapeutics, Inc.
$19
TherapeuticsMD, Inc.
$18
COLOPLAST CORP
$18
Antares Pharma, Inc.
$17
Telix Pharmaceuticals
$17
Retrophin, Inc.
$16
ACCORD HEALTHCARE, INC.
$16
Blue Earth Diagnostics Limited
$15
UroGen Pharma, Inc.
$15
UROGEN PHARMA, INC.
$13
Rochester Medical Corporation
$13
Metuchen Pharmaceuticals
$11
Janssen Pharmaceuticals, Inc
$9
Ambu Inc.
$6
Top 3 companies account for 34.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AQUABEAM SYSTEM · AVEED · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · Desara · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL ONCOLOGY · GENTLECATH · GREENLIGHT · GentleCath · ILLUCCIX · IMVEXXY · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · ORGOVYX · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Rivfloza · SPRIX · Sonablate · SpeediCath · Stendra · THROMBIN-JMI · UROLIFT · UroLift · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Orchard Park?
Compare urology physicians in the Orchard Park area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
44
Per 100K population
4.6
County median income
$71,175
Nearest hospital
WESTERN NY CHILDRENS PSYCHIATRIC CENTER
5.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sheldon is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sheldon experienced with automated urinalysis?
Based on Medicare claims data, Dr. Sheldon performed 769 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sheldon receive payments from pharmaceutical companies?
Yes. Dr. Sheldon received a total of $6,048 from 52 companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sheldon's costs compare to other urology physicians in Orchard Park?
Dr. Sheldon's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sheldon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →